125 Shares in Stryker Co. (NYSE:SYK) Acquired by HBC Financial Services PLLC

HBC Financial Services PLLC acquired a new position in Stryker Co. (NYSE:SYK) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 125 shares of the medical technology company’s stock, valued at approximately $37,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in SYK. Freedom Wealth Alliance LLC acquired a new position in shares of Stryker in the fourth quarter worth $26,000. Farmers & Merchants Trust Co of Chambersburg PA increased its position in Stryker by 203.3% during the fourth quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 91 shares of the medical technology company’s stock worth $27,000 after buying an additional 61 shares during the last quarter. Quarry LP acquired a new position in Stryker during the first quarter worth $27,000. Rise Advisors LLC increased its position in Stryker by 692.9% during the third quarter. Rise Advisors LLC now owns 111 shares of the medical technology company’s stock worth $30,000 after buying an additional 97 shares during the last quarter. Finally, Cornerstone Planning Group LLC acquired a new position in Stryker during the second quarter worth $38,000. 77.09% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Stryker news, Director Allan C. Golston sold 3,273 shares of the stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $341.00, for a total transaction of $1,116,093.00. Following the transaction, the director now owns 14,242 shares in the company, valued at approximately $4,856,522. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Stryker news, CAO William E. Berry, Jr. sold 7,690 shares of the company’s stock in a transaction that occurred on Thursday, March 7th. The shares were sold at an average price of $358.48, for a total value of $2,756,711.20. Following the completion of the transaction, the chief accounting officer now directly owns 3,675 shares in the company, valued at approximately $1,317,414. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Allan C. Golston sold 3,273 shares of the company’s stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $341.00, for a total transaction of $1,116,093.00. Following the completion of the transaction, the director now owns 14,242 shares of the company’s stock, valued at $4,856,522. The disclosure for this sale can be found here. Insiders have sold a total of 212,109 shares of company stock worth $72,845,768 in the last quarter. Corporate insiders own 5.90% of the company’s stock.

Stryker Stock Down 0.6 %

SYK traded down $2.08 during trading on Thursday, hitting $345.25. The company had a trading volume of 173,005 shares, compared to its average volume of 1,250,918. The firm’s 50-day moving average price is $350.71 and its 200 day moving average price is $309.75. The company has a quick ratio of 0.97, a current ratio of 1.58 and a debt-to-equity ratio of 0.59. Stryker Co. has a one year low of $249.98 and a one year high of $361.41. The company has a market capitalization of $131.36 billion, a PE ratio of 42.10, a PEG ratio of 2.82 and a beta of 0.89.

Stryker (NYSE:SYK) last released its quarterly earnings data on Tuesday, January 30th. The medical technology company reported $3.46 earnings per share for the quarter, topping the consensus estimate of $3.27 by $0.19. The company had revenue of $5.82 billion for the quarter, compared to analyst estimates of $5.60 billion. Stryker had a net margin of 15.44% and a return on equity of 22.99%. Stryker’s revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period in the previous year, the business earned $3.00 EPS. As a group, equities analysts expect that Stryker Co. will post 11.86 earnings per share for the current year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 30th. Investors of record on Friday, March 29th will be paid a $0.80 dividend. The ex-dividend date is Wednesday, March 27th. This represents a $3.20 dividend on an annualized basis and a yield of 0.93%. Stryker’s dividend payout ratio (DPR) is currently 38.79%.

Analyst Upgrades and Downgrades

Several research firms have commented on SYK. Roth Mkm increased their target price on shares of Stryker from $345.00 to $348.00 and gave the stock a “buy” rating in a research report on Wednesday, January 31st. Wells Fargo & Company raised their price target on shares of Stryker from $336.00 to $364.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 31st. Evercore ISI raised their price target on shares of Stryker from $340.00 to $370.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Citigroup lifted their target price on shares of Stryker from $362.00 to $406.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Finally, Canaccord Genuity Group upgraded shares of Stryker from a “hold” rating to a “buy” rating and set a $360.00 target price for the company in a research note on Wednesday, January 31st. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, Stryker presently has a consensus rating of “Moderate Buy” and a consensus price target of $335.27.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.